Sphingolipids in Genetic and Acquired Forms of Chronic Kidney Diseases

E-ISSN： 1875-533x|24|12|1238-1275

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.12, 2017-06, pp. : 1238-1275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Biological Activity of Nitric Oxide-releasing Derivatives of Ferulic Acid as Potential Agents for the Treatment of Chronic Kidney Diseases

Medicinal Chemistry, Vol. 9, Iss. 6, 2013-09 ,pp. : 875-880

Bentham Science Publishers

Access to resources Recommend Favorite

Multisystem diseases and the kidney

By Metcalfe Wendy Dudley Christopher

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 188-191

Royal College Of Physicians

Access to resources Recommend Favorite

Kidney Diseases and Chemokines

Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. : 65-80

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Mechanisms and Kidney Diseases

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1733-1739

Bentham Science Publishers

Access to resources Recommend Favorite

Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. : 590-595

Bentham Science Publishers

Access to resources Recommend Favorite